OTHER INFORMATION
−Removed: Not applicable.
+Added: Rule 10b5-1 Trading Plans
+Added: The following table shows the “Rule 10b5-1 trading arrangements” and “non-Rule 10b5-1 trading arrangements” (as each term is defined in Item 408(a) of Regulation S-K) adopted or terminated by our directors and executive officers during the quarter ended June 30, 2023:
+Added: Trading Arrangement
+Added: Name and Position Action Date Rule 10b5-1* Non-Rule
+Added: 10b5-1** Total Number of
+Added: Shares to be Sold Expiration Date
+Added: Adopt 6/16/2023 X 8,000 6/3/2024
+Added: Terminate (1)
+Added: 5/11/2023 X 7,000 5/11/2023
+Added: * Intended to satisfy the affirmative defense of Rule 10b5-1(c).
+Added: ** Not intended to satisfy the affirmative defense of Rule 10b5-1(c).
+Added: (1) Trading arrangement was originally adopted on June 13, 2022 .
Pacira BioSciences, Inc.
2 unchanged sentences
Exhibit Number Description
−Removed: Executive Employment Agreement, dated June 17, 2019, between the Registrant and Daryl Gaugler.* †
−Removed: Executive Employment Agreement, dated December 6, 2016, between the Registrant and Anthony Molloy.* †
−Removed: Credit Agreement, dated March 31, 2023, among Pacira BioSciences, Inc., the lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed on April 3, 2023).
+Added: Amended and Restated 2011 Stock Incentive Plan.(1)†
+Added: Side Letter dated June 5, 2023, to the Manufacturing and Supply Agreement by and between the Registrant and Patheon UK Limited.††
Certification of Chief Executive Officer and Chairman pursuant to Rule 13a-14(a) and 15d-14(a), as amended.*
3 unchanged sentences
101 The following materials from the Quarterly Report on Form 10-Q of Pacira BioSciences, Inc.
−Removed: for the quarter ended March 31, 2023, formatted in iXBRL (Inline eXtensible Business Reporting Language):
+Added: for the quarter ended June 30, 2023, formatted in iXBRL (Inline eXtensible Business Reporting Language):
(i) the Condensed Consolidated Balance Sheets;
(ii) the Condensed Consolidated Statements of Operations;
−Removed: (iii) the Condensed Consolidated Statements of Comprehensive (Loss) Income;
+Added: (iii) the Condensed Consolidated Statements of Comprehensive Income;
(iv) the Condensed Consolidated Statements of Stockholders’ Equity;
5 unchanged sentences
† Denotes management contract or compensatory plan or arrangement.
+Added: †† Certain portions of the exhibit have been omitted pursuant to Rule 601(b)(10) of Regulation S-K.
+Added: The omitted information is (i) not material and (ii) would cause competitive harm to the Company if publicly disclosed.
+Added: (1) Incorporated by reference to the Registrant’s Current Report on Form 8-K, filed on June 20, 2023.
Pacira BioSciences, Inc.
2 unchanged sentences
PACIRA BIOSCIENCES, INC.
−Removed: May 3, 2023 By:
+Added: August 2, 2023 By:
/s/ DAVID STACK
1 unchanged sentence
(Principal Executive Officer)
−Removed: May 3, 2023 By:
+Added: August 2, 2023 By:
/s/ CHARLES A.
6 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.